On a beautiful day in Los Angeles, Brinter held a press conference and launch event at Finland’s consulate general’s residence, where we had invited biotech professionals, scientists and investors from the LA region. Our Inc CEO Tom Alapaattikoski gave a warm welcoming speech, and after our Senior Advisor Nureddin Ashammakhi, from Michigan State University presented the today and future of 3D bioprinting and regenerative medicine. This was followed by our Chief Science Officer, Antti Arjonen, giving our Brinter’s Technology presentation. We all enjoyed a traditional Finnish lunch, with meatballs and lox.
The event was a complete success and our US corporation was officially announced with excitement!
